1. From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies

   • P.D. Ottewell
   • R.E. Coleman
   • I. Holen

   Review 01 December 2005 Pages: 101 - 113

2. Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with ^99mTc

   • Juan P. Oliva
   • Zodilina Valdés
   • Luis E. Fernández

   OriginalPaper 02 December 2005 Pages: 115 - 121

3. Use of raloxifene among women with a history of breast cancer

   • Laurel A. Habel
   • Alice Pressman
   • Charles P. Quesenberry

   Original Report 01 December 2005 Pages: 123 - 129

4. Bidirectional cross talk between ERα and EGFR signalling pathways regulates tamoxifen-resistant growth

   • D.J. Britton
   • I.R. Hutcheson
   • R.I. Nicholson

   Preclinical study 27 October 2005 Pages: 131 - 146

5. Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade

   • Kendall Wu
   • Elizabeth DuPré
   • Powel H. Brown

   Preclinical study 05 November 2005 Pages: 147 - 157

6. EcoRI polymorphism of the metastasis-suppressor gene NME1 in Mexican patients with breast cancer

   • Susan Andrea Gutierrez Rubio
   • Silvia Esperanza Flores Martinez
   • Maria Cristina Moran Moguel

   Preclinical Study 30 November 2005 Pages: 159 - 161

7. Neuregulins 1–4 are expressed in the cytoplasm or nuclei of ductal carcinoma (in situ) of the human breast

   • Catherine Marshall
   • Edith Blackburn
   • William J. Gullick

   Preclinical study 27 October 2005 Pages: 163 - 168

8. Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells

   • C.P. Muir
   • M.A. Adams
   • C.H. Graham

   Preclinical study 06 December 2005 Pages: 169 - 176

9. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model

   • Maria J. Worsham
   • Gerard Pals
   • Sandra R. Wolman

   Preclinical study 30 November 2005 Pages: 177 - 186

10. A possible regulatory role of 17β-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells

    • Antonio Rulli
    • Cinzia Antognelli
    • Vincenzo Talesa

    Preclinical study 01 December 2005 Pages: 187 - 196

11. Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women

    • Kyoung-Mu Lee
    • Sue Kyung Park
    • Daehee Kang

    OriginalPaper 30 November 2005 Pages: 197 - 202